JITC's COVID-19 and Cancer Immunotherapy Review Series
The latest special series from JITC, COVID-19 and Cancer Immunotherapy, edited by Paolo Antonio Ascierto, MD and Jason Goldman, MD, MPH, and authored by leading voices in the immuno-oncology, infectious disease, and virology fields, is a set of authoritative reviews that serves as a valuable resource illustrating the impact COVID-19 has on cancer patients undergoing immunotherapy, providing guidance on clinical decision-making, and offering insights on the use of immunotherapy to treat COVID-19 manifestations.
EXPLORE THE SERIES
COVID-19 Publications in JITC
All COVID-19 content in JITC has been curated into one collection for quick, easy access to publications from researchers and clinicians across the globe.